Particle Data Platform

Pancreatic Cancer Survival Breakthrough

1:15:391:16:05 · 26s

A personalized mRNA neoantigen therapy leaves half of terminal pancreatic-cancer patients cancer-free years later—unheard-of results for a deadly cancer.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.